enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.

  3. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

  4. Crenezumab - Wikipedia

    en.wikipedia.org/wiki/Crenezumab

    Crenezumab was developed by Ruth Greferath, Ph.D., and Claude Nicolau, Ph.D., before the Swiss-based biopharmaceutical company AC Immune was founded, which focuses on developing targeted therapeutics for misfolded proteins that cause neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. [4]

  5. How a new FDA-approved drug can — and can’t — help people ...

    www.aol.com/lifestyle/fda-approved-drug-t-help...

    Alzheimer’s facts and figures: Alzheimer’s Association FDA approval of Leqembi: U.S. Food and Drug Administration Leqembi study: New England Journal of Medicine

  6. FDA To Review New Alzheimer's Drug Leqembi and How ... - AOL

    www.aol.com/fda-review-alzheimers-drug-leqembi...

    An Alzheimer’s disease drug may soon have a new dosing schedule. The medication, Leqembi, is currently administered via an infusion every two weeks. Under the proposed changes, the medication ...

  7. Everything we know about breakthrough Alzheimer’s drug Donanemab

    www.aol.com/everything-know-breakthrough...

    A new Alzheimer's drug is being hailed as a "turning point" in the fight against the disease, with researchers saying it marks the beginning of a "new era where Alzheimer's could become treatable".

  8. With Alzeimer’s drug Leqembi getting full FDA approval ...

    www.aol.com/alzeimer-drug-leqembi-getting-full...

    With full FDA approval for the groundbreaking Alzheimer’s drug Leqembi, Medicare coverage takes a big step forward into a new era of treatment.

  9. Glycerophosphorylcholine - Wikipedia

    en.wikipedia.org/wiki/Glycerophosphorylcholine

    It is also a parasympathomimetic acetylcholine precursor [1] which has been investigated for its potential for the treatment of Alzheimer's disease [2] and other dementias. [3] Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. [2] It is a non-prescription drug in ...